Multiple types of cancer, including prostate adenocarcinoma and endometrial carcinoma, have elevated levels of Syn1 expression with further upregulation of Syn1 associated with cancer progression9,29. This evidence concerns the gene SYN1 and prostate adenocarcinoma.